IB Acquisition Corp. IBAC
are a blank check company formed under the laws of the State of Delaware on July 7, 2020 and which converted to a Nevada corporation
on September 21, 2023. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.
Our investment strategy is not specific to any sector; however, the management team and board members believe there are compelling investment
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| SG&A | $748.9K | $524.0K | $6.8K | — |
| Operating income | -$748.9K | -$524.0K | -$6.8K | — |
| Interest expense | — | $3.0M | — | — |
| Pre-tax income | $4.4M | $2.5M | -$6.8K | — |
| Income tax | $965.6K | $635.5K | — | — |
| Net income | $3.4M | $1.9M | -$6.8K | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | $428.7K | $822.8K | $52.6K | — |
| Total current assets | $1.2M | $1.2M | $52.6K | — |
| Total assets | $17.1M | $119.8M | $52.6K | — |
| Accounts payable | $73.8K | $86.7K | $8.0K | — |
| Total current liabilities | $1.8M | $722.2K | $58.0K | — |
| Total liabilities | $1.8M | $722.2K | $58.0K | — |
| Retained earnings | -$681.7K | $1.1M | -$8.4K | — |
| Total equity | -$681.3K | $1.1M | -$5.4K | $1.4K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating cash flow | -$1.3M | -$821.0K | -$207 | — |
| Investing cash flow | $107.8M | -$115.6M | — | — |
| Financing cash flow | -$106.1M | $117.2M | $50.0K | — |
| Buybacks | $106.1M | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-034626.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Net income | — | -$6.8K | $1.9M | $3.4M |
Recent filings and events
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Material agreement signed Item 1.01
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Material agreement signed Item 1.01
- Charter or fiscal year changed Item 5.03
- Shareholder vote Item 5.07
- Annual report filed Form 10-K
- Auditor changed The company changed auditors. Sometimes routine; historically one of the more reliable warnings that something is wrong. Item 4.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 8731
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| IQV | IQVIA HOLDINGS INC. | $46.63B | 35.6x | 5.9% |
| INCY | INCYTE CORP | $23.12B | 18.1x | 21.2% |
| MEDP | Medpace Holdings, Inc. | $18.68B | 43.8x | 20.0% |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $16.49B | — | -0.9% |
| ABSI | Absci Corp | $1.58B | — | -38.2% |
| OABI | OmniAb, Inc. | $677.5M | — | -29.3% |
| NRC | NRC HEALTH | $485.1M | 0.4x | -4.0% |
| ONMD | OneMedNet Corp | $279.2M | — | 111.4% |